まとめ
カイン酸は,特定の小脳ニューロンを選択的に破壊し,粒子の細胞を節約します. この神経毒性は,カイン酸がグルタミン酸受容体を通して作用するという仮説を支持する.
科学分野:
- 神経科学は神経科学である.
- 神経毒理学 神経毒理学について
背景:
- グルタミン酸は,中枢神経系の主要な刺激性神経伝達物質です.
- カイン酸は,グルタミン酸受容体を研究するために使用されるグルタミン酸アナログです.
研究 の 目的:
- ケイン酸が小脳ニューロンに及ぼす神経毒性作用を調査する.
- 小脳におけるカイン酸神経毒性の選択性を決定する.
主な方法:
- 大人のハムスターとネズミの小脳にカイン酸を微量注入する.
- 神経細胞の生存と退廃を評価するための組織学的検査.
主要な成果:
- カイン酸は,プルキニエ,バスケット,ステラート,ゴルギII細胞の急速な退化を引き起こした.
- これらのニューロンからインプットを受け取る粒状細胞は,救われました.
- 選択的毒性は,グルタミン酸受容体を含むメカニズムを示唆しています.
結論:
- カイン酸は,小脳内で選択的な神経毒性を示します.
- この発見は,カイン酸の神経毒性作用を媒介するグルタミン酸受容体の役割を支持しています.
関連する概念動画
Excitatory and Inhibitory Effects of Neurotransmitters
When an action potential reaches the presynaptic axon terminal, it releases neurotransmitters from the neuron into the synaptic cleft at a chemical synapse. The released neurotransmitter can be excitatory or inhibitory. The critical criteria commonly used to determine whether a molecule is a neurotransmitter at a chemical synapse are the molecule's presence in the presynaptic neuron. Second, its release is in response to strong presynaptic depolarization. And lastly, the presence of specific...
Neurochemical Transmission: Sites of Drug Action
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
Cholinergic Neurons: Neurotransmission
Cholinergic neurotransmission involves the synthesis and the release of acetylcholine (ACh) in order to transmit nerve impulses across the synapse. The process begins with the synthesis of acetyl CoA, a precursor for ACh, from ATP, acetate, and coenzyme A in the mitochondria. Choline, another vital precursor, is transported inside the neuron through choline transporters, including high-affinity choline transporter CHT1, low-affinity choline transporter CTL1, and lower-affinity choline...
Adrenergic Neurons: Neurotransmission
Postganglionic sympathetic fibers (except those supplying the sweat glands) releasing noradrenaline or norepinephrine are called noradrenergic or adrenergic neurons. Noradrenaline, dopamine, adrenaline, or epinephrine are collectively called "catecholamines" as they contain a catechol moiety and an amine side chain. The five stages of neurotransmitter release involve their synthesis, storage, release, reuptake and metabolism.
Synthesis: Catecholamine synthesis requires tyrosine, which is taken...
Synthesis: Catecholamine synthesis requires tyrosine, which is taken...
Drugs Affecting Neurotransmitter Release or Uptake
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
Drugs Affecting Neurotransmitter Synthesis
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...


